The Clorox Company $CLX Shares Sold by Hsbc Holdings PLC

Hsbc Holdings PLC reduced its stake in shares of The Clorox Company (NYSE:CLX) by 9.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 399,264 shares of the company’s stock after selling 43,003 shares during the quarter. Hsbc Holdings PLC owned 0.33% of Clorox worth $40,332,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of the stock. Norges Bank acquired a new stake in shares of Clorox during the 4th quarter worth approximately $135,735,000. Van ECK Associates Corp lifted its stake in shares of Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares during the period. Invesco Ltd. lifted its stake in shares of Clorox by 22.1% in the 4th quarter. Invesco Ltd. now owns 4,880,341 shares of the company’s stock valued at $492,085,000 after purchasing an additional 884,751 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in Clorox by 6,907.9% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock worth $75,593,000 after buying an additional 739,005 shares in the last quarter. Finally, Worldquant Millennium Advisors LLC purchased a new stake in Clorox during the second quarter worth $71,856,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. The Goldman Sachs Group reaffirmed a “sell” rating and issued a $83.00 price objective on shares of Clorox in a report on Friday, May 1st. Jefferies Financial Group lowered their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Wells Fargo & Company dropped their target price on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a research report on Monday, May 18th. Morgan Stanley cut their price target on Clorox from $110.00 to $97.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Finally, Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. One equities research analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat, Clorox has an average rating of “Reduce” and an average target price of $103.40.

Insiders Place Their Bets

In other news, Director Pierre R. Breber acquired 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the acquisition, the director owned 18,000 shares in the company, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.63% of the company’s stock.

Clorox Stock Performance

NYSE:CLX opened at $92.55 on Wednesday. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The company has a fifty day moving average of $95.12 and a two-hundred day moving average of $104.61. The stock has a market capitalization of $11.19 billion, a PE ratio of 15.02, a P/E/G ratio of 0.47 and a beta of 0.56. The Clorox Company has a fifty-two week low of $84.70 and a fifty-two week high of $132.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. The business had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company’s revenue was up .1% compared to the same quarter last year. During the same period last year, the firm posted $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, research analysts forecast that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.